These are mechanically computed values based on a residual income model. They are not a forecast of market prices or a recommendation of any investment action, and do not predict or guarantee future share prices. Historical values are computed retrospectively using current guidance-achievement statistics.
| Metric | Current Period | Same Period Last Year | YoY |
|---|---|---|---|
| Revenue | ¥9.75B | ¥8.80B | +10.9% |
| Operating Income | ¥1.24B | ¥1.22B | +1.6% |
| Ordinary Income | ¥1.18B | ¥1.15B | +2.4% |
| Net Income | ¥1.10B | ¥0.83B | +32.9% |
| ROE | 2.3% | 1.7% | - |
Although revenue growth was secured in Q1 of the fiscal year ending March 2027, the slowdown in gross margin limited the expansion of the core business, while the substantial increase in net income was supported by the recognition of extraordinary income. Revenue was ¥9.75B (+10.9% YoY), Operating Income was ¥1.24B (+1.6%), and Ordinary Income was ¥1.18B (+2.4%). Net Income attributable to owners of the parent increased significantly to ¥1.09B (+32.1%), primarily due to the recognition of ¥0.29B in extraordinary income, including a ¥0.276B gain on changes in equity interests. The Operating Income margin declined to 12.7% from 13.9% in the same period of the previous year. While the Operating Income margin in the core High-Purity Chemicals segment declined to 10.8%, the Transportation segment achieved double-digit growth in both revenue and profit, supporting the overall results.
【Revenue】Revenue increased 10.9% YoY to ¥9.75B. By segment, on a total basis including inter-segment transactions, High-Purity Chemicals generated ¥8.38B (+10.2%), accounting for 76.8% of total revenue and maintaining its position as the core business, while Transportation increased 18.3% to ¥2.43B, raising its composition ratio through double-digit growth. Other Businesses, including insurance agency services and automotive maintenance, generated ¥0.09B (+5.7%). Transportation grew relatively faster, and the segment mix is shifting toward Transportation.
【Profit and Loss】Operating Income was limited to ¥1.24B (+1.6%), with growth remaining modest relative to the increase in revenue. The gross margin was 23.2%, down approximately 1.7pt from 24.9% in the previous year, suggesting the impact of higher costs and changes in pricing and product mix. Meanwhile, the SG&A ratio improved by approximately 0.5pt to 10.5%, compared with 10.5% (11.0%) in the previous year, indicating progress in cost efficiency. Ordinary Income was ¥1.18B (+2.4%). In non-operating income and expenses, dividend income of ¥0.02B was more than offset by foreign exchange losses of ¥0.07B and interest expenses of ¥0.02B, resulting in a net non-operating expense excess of ¥0.07B. The recognition of ¥0.29B in extraordinary income, primarily a ¥0.28B gain on changes in equity interests, lifted Profit Before Tax to ¥1.46B (+26.2%). Following an effective tax rate of 24.8%, Net Income attributable to owners of the parent amounted to ¥1.09B (+32.1%). In conclusion, although the Company achieved revenue and profit growth, the increase at the operating level was limited, and the growth in net income depended substantially on temporary extraordinary income.
High-Purity Chemicals recorded revenue of ¥8.38B (+10.2%), Operating Income of ¥0.90B (-9.6%), and an Operating Income margin of 10.8% (13.1% in the previous year), indicating declines in both profit and margin. Despite being the core business, profitability weakened and was the primary factor depressing the Company-wide Operating Income margin. Transportation recorded revenue of ¥2.43B (+18.3%), Operating Income of ¥0.34B (+49.1%), and a margin of 13.9% (approximately 11.0% in the previous year), demonstrating notable growth in both revenue and profit as well as margin improvement, thereby contributing to an improvement in the overall business mix. Other Businesses generated revenue of ¥0.09B (+5.7%) and Operating Income of ¥0.003B (+50.0%), with a margin of 3.2%, although its scale is small. Overall, the expansion of the highly profitable Transportation segment partially offset the margin decline in High-Purity Chemicals.
【Profitability】The Operating Income margin was 12.7%, down approximately 1.2pt from 13.9% in the previous year, while the gross margin also declined approximately 1.7pt to 23.2% from 24.9%, indicating a modest deterioration in core business profitability. Meanwhile, the Net Income margin attributable to owners of the parent improved to 11.2% from 9.4% in the previous year, but this was attributable to the contribution from extraordinary income. 【Cash Quality】Cash and deposits were ¥12.93B, down ¥1.89B from ¥14.82B in the previous year, while accounts receivable increased to ¥7.60B (+3.7%) and inventories increased to ¥2.92B (+21.5%), indicating an expansion in working capital. 【Investment Efficiency】ROE was 2.3% (quarterly basis, not annualized), comprising a Net Income margin of 11.2%, quarterly total asset turnover of approximately 0.15x, and financial leverage of approximately 1.33x. The low total asset turnover was a factor suppressing ROE. 【Financial Soundness】The Equity Ratio was 75.5%, improving from approximately 74.9% in the previous year. Liquidity was extremely high, with a current ratio of 326.1% and a quick ratio of 292.5%. Interest-bearing debt was ¥5.27B, while cash of ¥12.93B exceeded this amount, resulting in net cash of ¥7.66B and a substantial financial buffer.
As an individual disclosure of the statement of cash flows is not available, cash flow trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥12.93B, a decrease of ¥1.89B from ¥14.82B in the same period of the previous year. In terms of working capital, accounts receivable increased to ¥7.60B (+3.7%) and inventories expanded to ¥2.92B (+21.5%, including an increase of the same magnitude in finished goods inventories), while accounts payable increased to ¥2.43B (+20.0%). However, other accounts payable declined to ¥0.95B (-23.2%), and accrued income taxes declined to ¥0.37B (-48.9%), suggesting that changes in operating liabilities and tax payments may have been sources of cash outflow. Interest-bearing debt was ¥5.27B, slightly reduced from ¥5.56B in the previous year, and no significant financing or repayment activity was observed. Construction in progress was ¥5.15B (¥5.35B in the previous year), maintaining a high investment pipeline, and capital expenditures continued. The decline in cash and increases in inventories and accounts receivable indicate the impact of working capital expansion accompanying revenue growth on cash efficiency. Trends in the collection cycle will determine future cash generation capacity.
Recurring earnings capacity is reflected in Operating Income of ¥1.24B and Ordinary Income of ¥1.18B. During the current period, however, the Company recorded ¥0.29B in extraordinary income, including a ¥0.28B gain on changes in equity interests and a ¥0.01B gain on the sale of fixed assets. After deducting ¥0.002B in extraordinary losses, the resulting net amount of approximately ¥0.28B represented approximately 19% of Profit Before Tax of ¥1.46B and approximately 26% of Net Income attributable to owners of the parent of ¥1.09B. Accordingly, a substantial portion of the increase in net income (+32.1%) depended on non-recurring temporary factors, and attention should be paid to the significant divergence from the growth in Operating Income (+1.6%) and Ordinary Income (+2.4%). Non-operating income and expenses resulted in a net expense excess of ¥0.07B, primarily due to foreign exchange losses of ¥0.07B. Comprehensive income was ¥1.10B, including ¥1.09B attributable to owners of the parent, roughly in line with Net Income of ¥1.09B. Within the components, however, foreign currency translation adjustments of +¥0.20B and valuation difference on available-for-sale securities of -¥0.25B offset each other, indicating that fluctuations in asset valuations affected the internal composition of comprehensive income.
Progress toward the full-year plan—revenue of ¥39.10B, Operating Income of ¥4.80B, Ordinary Income of ¥4.90B, and Net Income of ¥3.40B—was 24.9% for revenue, 25.9% for Operating Income, 24.0% for Ordinary Income, and 32.2% for Net Income in Q1. Compared with the benchmark of 25% for evenly distributed quarterly progress, revenue, Operating Income, and Ordinary Income were broadly on a standard trajectory, while Net Income was somewhat ahead at 32.2%. This reflects the recognition of ¥0.29B in extraordinary income and does not directly indicate the trend in core earnings throughout the full year. Neither the earnings forecast nor the dividend forecast was revised as of the current quarter.
The full-year dividend forecast is ¥180 per share, representing an increase from the previous fiscal year’s actual dividend of ¥85 per share, comprising the interim and year-end dividends. Based on the Company’s forecast EPS of ¥278.55, the Payout Ratio is approximately 64.6%, a relatively high level. However, abundant funds on hand, including cash and deposits of ¥12.93B and net cash of ¥7.66B, support the stability of the dividend funding base. No information on share buybacks has been disclosed, and it is appropriate to evaluate shareholder returns based on the Payout Ratio.
Declining profitability in the core segment: The Operating Income margin of High-Purity Chemicals, which accounts for 76.8% of revenue, declined to 10.8% from 13.1% in the previous year. Changes in raw material costs, pricing, and product mix could therefore have a significant impact on Company-wide profitability.
Expansion in working capital: Inventories increased to ¥2.92B (+21.5%), and accounts receivable increased to ¥7.60B (+3.7%). The impact of inventory and receivables accumulation on cash efficiency needs to be monitored.
Volatility in non-operating income and expenses: Foreign exchange losses of ¥0.07B were incurred, weighing on the growth in Ordinary Income (+2.4%). Foreign exchange trends therefore represent a source of earnings volatility below the operating level.
Profitability and Return
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 12.7% | 8.7% (4.2%–14.2%) | +4.0pt |
| Net Income Margin | 11.3% | 7.0% (3.2%–10.6%) | +4.2pt |
The Company’s Operating Income margin and Net Income margin both exceed the industry median, placing its profitability at a relatively high level.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 10.9% | 6.2% (-1.1%–14.6%) | +4.7pt |
The revenue growth rate also exceeds the industry median but has not reached the upper quartile boundary (14.6%), placing the Company in the upper group within the industry.
※Source: Compiled by the Company
The 1.6% increase in Operating Income was modest relative to the 10.9% increase in revenue, and the approximately 1.7pt YoY decline in gross margin is noteworthy as a trend in core business profitability.
The 32.1% increase in Net Income attributable to owners of the parent depended substantially on the recognition of extraordinary income, primarily the ¥0.28B gain on changes in equity interests. The divergence from the growth in recurring earnings capacity, represented by the 2.4% increase in Ordinary Income, is significant.
By segment, the highly profitable expansion of Transportation, with a 13.9% margin, partially offset the margin decline in the core High-Purity Chemicals segment, whose margin fell to 10.8%. This indicates a change in the earnings structure within the business portfolio.
This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson-type model with an explicit five-year fade period). It is not a forecast of the market share price or a recommendation of any specific investment action.
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥3,618 |
| base | ¥3,688 |
| bull | ¥3,744 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥3,911 |
| Adjusted Forecast EPS | ¥299.4 |
| Cost of Equity r | 9.77% (10-year Japanese government bond 2.77% + equity risk premium 6.00% + size premium 1.00%) |
| Residual Income Persistence Coefficient ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 64.6% |
| Forecast EPS Confidence Adjustment | ×1.075 (based on the industry’s historical guidance achievement rate) |
| Implied PBR / PER |
Sensitivity: ¥3,590–¥3,790 at ±1% for the cost of equity, and ¥3,681–¥3,692 at ±0.1 for ω.
Notes:
(Calculation model: Residual Income Model / Interest rate reference month: 2026-07 / This value does not forecast or guarantee future share prices)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with a professional as necessary.
---End of Report---
| 0.94x / 12.3x |